These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7236488)

  • 41. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
    Stephens TC; Adams K; Peacock JH
    Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
    Roizin-Towle LA; Hall EJ
    Br J Cancer; 1981 Aug; 44(2):201-7. PubMed ID: 6168277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The combination of 5-fluorouracil with misonidazole in patients with advanced colorectal cancer.
    Spooner D; Bugden RD; Peckham MJ; Wist EA
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):387-9. PubMed ID: 7107357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Azomycin riboside: a new radiosensitizer.
    Pedersen JE; Barron G; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):415-8. PubMed ID: 7107360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is tumour radiosensitization by misonidazole a general phenomenon?
    Denekamp J; Hirst DG; Stewart FA; Terry NH
    Br J Cancer; 1980 Jan; 41(1):1-9. PubMed ID: 7362769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
    Abratt RP
    Br J Cancer; 1982 Dec; 46(6):976-9. PubMed ID: 7150492
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
    Overgaard J; Overgaard M; Nielsen OS; Pedersen AK; Timothy AR
    Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of timing on chemosensitization by clinical levels of SR-2508.
    Hirst DG; Horsman MR; Brown JM; Hazlehurst JL
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1641-5. PubMed ID: 6237082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination therapy with misonidazole and mitomycin C: lack of chemosensitization of EMT6 tumor cells in vivo or in vitro.
    Rockwell S
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1631-4. PubMed ID: 6434497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Enhancement of MeCCNU potency (chemosensitization) by misonidazole in a human melanoma xenograft system].
    Osieka R; Glatte P; Haedecke U; Schmidt CG
    Strahlentherapie; 1982 Oct; 158(10):620-9. PubMed ID: 7179344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of radiosensitizers in combination with chemotherapeutic agents in solid tumors.
    Clement JJ; Johnson RK
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):631-4. PubMed ID: 7107387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The response of mouse lung tumors to combinations of CCNU and misonidazole.
    Siemann DW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):627-30. PubMed ID: 7107386
    [No Abstract]   [Full Text] [Related]  

  • 55. In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.
    Mulcahy RT; Siemann DW; Sutherland RM
    Br J Cancer; 1981 Jan; 43(1):93-9. PubMed ID: 7459244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Broad-shouldered survival curves of a human melanoma xenograft. Implications for radiation therapy in the absence and presence of misonidazole.
    Rofstad EK; Brustad T
    Acta Radiol Oncol; 1981; 20(4):261-5. PubMed ID: 6277155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal interactions in the Lewis lung tumour between cytotoxic drugs and acute or fractionated radiotherapy.
    Stephens TC; Adams K; Peacock JH; Steel GG
    Radiother Oncol; 1986 Feb; 5(2):137-46. PubMed ID: 3704188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
    Mulcahy RT; Dembs NL; Ublacker GA
    Br J Cancer; 1984 Mar; 49(3):307-13. PubMed ID: 6704305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW; Morrissey S; Wolf K
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.